| High stakes trials often demand ready access to clinical comparator drugs that can be hard to procure and logistically challenging to supply, reports Angus G Cameron of Pharmarama. When it comes to sourcing comparators for global clinical trials; it’s about who – and what – you know
The procurement of a specific comparator drug – often an essential element in clinical pharmaceutical trials – and the management of its associated logistics is a complex, time-consuming process. With the enormous potential costs of even a slight mis-step in obtaining a suitable comparator, sourcing these drugs in a timely and effective manner is a critical competency for any company pursuing a global clinical trial.
With the costs for delays in many pivotal clinical trials exceeding $1 million per day (1), locating a specific comparator drug and managing the logistics of providing that drug for a clinical trial can seem an insurmountable task – one that is frequently outside the expertise of many pharmaceutical manufacturers. Amid the growing number of clinical trials underway worldwide and the increasing demand for comparator products used for these trials, the pressure is on to not only find the drug of choice, but to find it at the right time, in the right amounts and from a single batch, often in multiple foreign territories. |
